Skip to main content
Premium Trial:

Request an Annual Quote

Joshua Mann

Joshua Mann has joined Inspirata as vice president of the company's Cancer Information Data Trust. He will be responsible for aligning the CIDT business strategy with systems design and data flow, spanning data collection, organization and management, as well as data analysis and visualization. Mann has previously served as director of oncology technology solutions and acting chief technology officer for CancerLinQ, a subsidiary or the American Society of Clinical Oncology. He also cofounded SHARE for Cures, a non-profit organization that seeks to empower patients to use their individual health data to advance medical research. Immediately prior to joining Inspirata, Mann ran a consulting firm through which he served as a consulting chief information officer to Guardian Research Network.

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.